It wasn't that long ago this stock was trading in the two cent range. My head is finally above water on this stock and I know even better days are ahead. Let's just hang tight for news on EMA trial design. A strange thing I found in my last post was that the FDA is more likely to give expidited approval on less than stellat trial results than the EMA (time frame 2007 - 20017). Just thought that was an interesting tidbit.
Ann: ANP meeting with US FDA granted for ATL1102 in DMD, page-80
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |